New method for peptide desorption from abundant blood proteins for plasma/serum peptidome analyses by mass spectrometry

Journal of Proteomics

Volumn 74, Issue 5, 2011, Pages 595-606

  Ziganshin, Rustam ^a   Arapidi, Georgii ^a   Azarkin, Igor ^a   Zaryadieva, Elena ^a   Alexeev, Dmitry ^a   Govorun, Vadim ^a   Ivanov, Vadim ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Blood serum; Enrichment of peptides; Identification of blood serum peptides; MALDI TOF MS; Q TOF LC MS MS

Indexed keywords

PLASMA PROTEIN;

ADULT; ARTICLE; CHEMICAL REACTION; DISSOCIATION; FEMALE; FRACTIONATION; HEATING; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY;

BLOOD PROTEINS; FEMALE; HOT TEMPERATURE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79953302375     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.01.014     Document Type: Article

References (44)

1. Hu L., Boos K.S., Ye M., Wu R., Zou H. Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. J Chromatogr A 2009, 1216:5377-5384.
2. Shen Y., Liu T., Tolic N., Petritis B.O., et al. Strategy for degradomic-peptidomic analysis of human blood plasma. J Proteome Res 2010, 9:2339-2346.
3. Williams D., Ackloo S., Zhu P., Bowden P., et al. Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides. Anal Bioanal Chem 2010, 396:1223-1247.
4. Zheng X., Baker H., Hancock W.S. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 2006, 1120:173-184.
5. Drake R.R., Elschenbroich S., Lopez-Perez O., Kim Y., et al. In-depth proteomic analyses of direct expressed prostatic secretions. J Proteome Res 2010, 9:2109-2116.
6. Boschetti E., Lomas L., Citterio A., Righetti P.G. Romancing the "hidden proteome", Anno Domini two zero zero seven. J Chromatogr A 2007, 1153:277-290.
7. Boschetti E., Righetti P.G. The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J Proteomics 2008, 71:255-264.
8. Candiano G., Dimuccio V., Bruschi M., Santucci L., et al. Combinatorial peptide ligand libraries for urine proteome analysis: investigation of different elution systems. Electrophoresis 2009, 30:2405-2411.
9. Righetti P.G., Boschetti E., Lomas L., Citterio A. Protein Equalizer Technology: the quest for a "democratic proteome". Proteomics 2006, 6:3980-3992.
10. Righetti P.G., Boschetti E., Zanella A., Fasoli E., Citterio A. Plucking, pillaging and plundering proteomes with combinatorial peptide ligand libraries. J Chromatogr A 2010, 1217:893-900.
11. de Noo M.E., Deelder A., van der Werff M., Ozalp A., et al. MALDI-TOF serum protein profiling for the detection of breast cancer. Onkologie 2006, 29:501-506.
12. Ebert M.P., Niemeyer D., Deininger S.O., Wex T., et al. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J Proteome Res 2006, 5:2152-2158.
13. Kanmura S., Uto H., Kusumoto K., Ishida Y., et al. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology 2007, 45:948-956.
14. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002, 48:1296-1304.
15. Lopez M.F., Mikulskis A., Kuzdzal S., Golenko E., et al. A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clin Chem 2007, 53:1067-1074.
16. Merchant M., Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000, 21:1164-1177.
17. Shin S., Cazares L., Schneider H., Mitchell S., et al. Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg 2007, 204:1065-1071. discussion 1071-1063.
18. Skytt A., Thysell E., Stattin P., Stenman U.H., et al. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. Int J Cancer 2007, 121:615-620.
19. Smith F.M., Gallagher W.M., Fox E., Stephens R.B., et al. Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg 2007, 245:259-266.
20. Su Y., Shen J., Qian H., Ma H., et al. Diagnosis of gastric cancer using decision tree classification of mass spectral data. Cancer Sci 2007, 98:37-43.
21. Villanueva J., Philip J., Chaparro C.A., Li Y., et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 2005, 4:1060-1072.
22. Villanueva J., Philip J., Entenberg D., Chaparro C.A., et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 2004, 76:1560-1570.
23. Wang J.X., Yu J.K., Wang L., Liu Q.L., et al. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 2006, 6:5344-5349.
24. Whiteaker J.R., Zhang H., Eng J.K., Fang R., et al. Head-to-head comparison of serum fractionation techniques. J Proteome Res 2007, 6:828-836.
25. Zhang H., Kong B., Qu X., Jia L., et al. Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecol Oncol 2006, 102:61-66.
26. Zheng G.X., Wang C.X., Qu X., Deng X.M., et al. Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. Exp Oncol 2006, 28:282-287.
27. Zhou L., Cheng L., Tao L., Jia X., et al. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Acta Otolaryngol 2006, 126:853-860.
28. Zhu L.R., Zhang W.Y., Yu L., Zheng Y.H., et al. Serum proteomic features for detection of endometrial cancer. Int J Gynecol Cancer 2006, 16:1374-1378.
29. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
30. Luque-Garcia J.L., Neubert T.A. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry. J Chromatogr A 2007, 1153:259-276.
31. Tammen H., Schulte I., Hess R., Menzel C., et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5:3414-3422.
32. Di Girolamo F., Alessandroni J., Somma P., Guadagni F. Pre-analytical operating procedures for serum Low Molecular Weight protein profiling. J Proteomics 2010, 73:667-677.
33. Geho D.H., Liotta L.A., Petricoin E.F., Zhao W., Araujo R.P. The amplified peptidome: the new treasure chest of candidate biomarkers. Curr Opin Chem Biol 2006, 10:50-55.
34. Lowenthal M.S., Mehta A.I., Frogale K., Bandle R.W., et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005, 51:1933-1945.
35. Mehta A.I., Ross S., Lowenthal M.S., Fusaro V., et al. Biomarker amplification by serum carrier protein binding. Dis Markers 2003, 19:1-10.
36. Hortin G.L., Shen R.F., Martin B.M., Remaley A.T. Diverse range of small peptides associated with high-density lipoprotein. Biochem Biophys Res Commun 2006, 340:909-915.
37. Zhou M., Lucas D.A., Chan K.C., Issaq H.J., et al. An investigation into the human serum "interactome". Electrophoresis 2004, 25:1289-1298.
38. Araujo R.P., Petricoin E.F., Liotta L.A. Critical dependence of blood-borne biomarker concentrations on the half-lives of their carrier proteins. J Theor Biol 2008, 253:616-622.
39. Liotta L.A., Ferrari M., Petricoin E. Clinical proteomics: written in blood. Nature 2003, 425:905.
40. Liotta L.A., Petricoin E.F. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 2006, 116:26-30.
41. Petricoin E.F., Belluco C., Araujo R.P., Liotta L.A. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer 2006, 6:961-967.
42. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
43. Rappsilber J., Mann M., Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2007, 2:1896-1906.
44. Hsieh S.Y., Chen R.K., Pan Y.H., Lee H.L. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 2006, 6:3189-3198.